Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Lazarus

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
International Clinical Psychopharmacology|October 27, 2011
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studiesRichard H Weisler, Stuart A Montgomery, Willie R Earley, et al.
The Journal of Clinical Psychiatry|April 11, 2009
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled studyAndrew J Cutler, Stuart A Montgomery, David Feifel, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
Racial differences in medication switching and concomitant prescriptions in the treatment of bipolar disorderDavid Garver, Arthur Lazarus, Kitty Rajagopalan, et al.
The American Journal of Psychiatry|July 4, 2007
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparisonJoseph P McEvoy, Jeffrey A Lieberman, Diana O Perkins, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
International Clinical Psychopharmacology|October 27, 2011
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studiesRichard H Weisler, Stuart A Montgomery, Willie R Earley, et al.
The Journal of Clinical Psychiatry|April 11, 2009
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled studyAndrew J Cutler, Stuart A Montgomery, David Feifel, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
Racial differences in medication switching and concomitant prescriptions in the treatment of bipolar disorderDavid Garver, Arthur Lazarus, Kitty Rajagopalan, et al.
The American Journal of Psychiatry|July 4, 2007
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparisonJoseph P McEvoy, Jeffrey A Lieberman, Diana O Perkins, et al.
Pageof 7